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INTRODUCTION 
Snakebite is an important preventable health hazard. Patients with 
snake envenomation present as emergencies with significant morbidity 
and mortality. Snakebite is one of the occupational hazards and the 
majority affected belongs to the productive group of the population. The 
resulting high fatality rate due to snake bite remains largely unnoticed 
and neglected by the medical profession. 
While the precise figures for global snake bite epidemiology are 
not available, best of the estimates suggest that there are more than 2.5 
million venomous snake bites annually, with greater than 125,000 
deaths. The risk is highest in the tropics and West Africa, predominantly 
amongst the rural population. In India a large proportion of snake bites 
occur when people are working barefoot in the fields, or while walking 
at night or early morning through fields or along road side1.  
India an agricultural country looses substantial number of lives to 
snake bite. More than 2000000 snake bites are reported in the country 
annually and it is estimated that between 35000 and 50000 people die of 
snake bite each year in India2. This does not reflect the real situation as 
because majority of the cases are not reported.  Though underreported 
this mortality is one of the highest in the world. The main reasons for 
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the underreporting are people’s attitude of seeking indigenous 
medications in preference to modern health care facilities. Ignorance of 
conventional treatment of snake bite by the doctors further delays the 
proper treatment of the victims.  
The outcome of the snakebite treatment largely depends on time 
delay between snake bite and ASV administration3. There is higher 
incidence of renal failure, respiratory failure, prolonged hospital stay 
and blood products administration in those who reported to the hospital 
lately4. Many studies reveal that renal abnormality correlates well with 
late onset of treatment5. Irrationally used ASV increases morbidity and 
mortality, and also increases the burden on the health budget of the 
government.  
Community based studies with reference to demographical, 
sociocultural, clinical and economical implication should be carried out. 
With the analysis of the studies, various policy decisions can be made 
for revamping and revising the health projects and schemes. 
Sensitization of the public regarding the approach to snake bite victim, 
regulation of the media in reference to the dissemination of scientific 
information, addressing the policy makers to earmark funds for 
community education regarding snake bite and multipronged approach 
to snake bite as a whole is need of the hour. 
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AIMS AND OBJECTIVES 
To study the pattern of snake bite with reference to demographic 
profile, treatment preferences,  sociocultural beliefs, customs,  regional 
beliefs, accessibility of health care, obstacles met during seeking of 
health care, average time delay in seeking medical care,  dose of the first 
instituted ASV at the various primary health centers and district 
hospital, course of the patient in the hospital, treatment outcome and 
economic implication, impact of the snake bite on individual and 
community.  
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SNAKE BITE IN INDIA - A REVIEW 
Snakes fascinate us more than any other animals on earth. 
Because people don’t know much about them, snakes are misunderstood 
and feared. Of the 3000 species of snakes, about 500 belong to the three 
families of venomous snakes, 
¾ Atractaspididae 
¾ Elapidae 
¾ Viperidae 
Only about 200 species have caused death or permanent disability 
by biting humans. Bites by more than 30 species of the large family 
colubridae, once considered harmless, have produced signs of 
envenoming in man, while five of them have caused fatal envenoming6. 
Among the nonvenomous snakes, only the giant constrictors (family 
Boidae) are potentially dangerous to man. There have been a number of 
fatal attack by these snakes reported from Africa (rock python), south 
East Asia (especially Indonesia) (reticulate python) and South America 
(anaconda). Some of the victims, even adults, were swallowed. 
 5
There are over 270 different species of snakes in India. In India 
most of the snakes are absolutely harmless to humans while four species 
(cobra, saw-scaled viper, Russell’s viper, and krait) are responsible for 
thousands of deaths each year. Indian snakes range in size form a few 
centimeters to almost ten meters in length. Snakes live in scorching 
deserts, humid forests, and cool hill range, in lakes, streams and even in 
the sea. The variety of colors and patterns rivals the butterflies while 
their grace and fluidity are unmatched in nature. Snake behavior and 
adaptations are endlessly exciting but the first step is able to identify 
them. 
Snakes are classified morphologically by the arrangement of their 
scales (lepidosis), dentition, osteology, mycology, sensory organs, and 
the form of the hemipenes and increasingly by sequence analysis of 
DNA encoding important mitochondrial and other enzymes7. 
Legless lizards, such as slow worms, glass lizards, worm like 
geckos and legless skinks, may be distinguished from snakes by their 
eyelids, external ears, and friable tails and by the lack of enlarged 
ventral scales. Eels and pipe-shaped fish are distinguished from snakes 
by their gills and fins. 
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SENSES 
Snakes probably don’t see colour and many are near-sighted, 
including the vipers and all the burrowers. Tree snakes, rat snakes and 
king cobra all have good vision and can see  you coming from quite a 
far away(though how far is not yet known) (Romulus Whitaker., snakes 
of India) 
Snakes can smell with their nostrils but they rely mainly on the 
combination of their sensitive tongue (which picks up the odors) and the 
Jacobson’s organ in the roof of the mouth (where the odors are 
“decoded”)  
The heat sensitive “pits” between the nostrils and the eye in the 
pit vipers can detect temperature change as slight as three thousandths of 
a degree centigrade (0.003 C). Pits are very helpful in finding warm-
blooded rodents or birds or even a slightly warm frog or toad on a cool 
dark night. Pythons have similar infrared receptors along their upper 
lips.  
Snakes can actually “hear” low frequency sounds in the 200 to 
500 Hz range. They have no ears or eardrums but low sounds that hit the 
side of the skull are transferred to the inner ear through the jaw muscle 
and ear bone. They cannot hear sounds like talking, music or a gunshot. 
 7
Snakes are sensitive to vibrations through the ground and in this way 
can feel you walking past. 
FEEDING 
All snakes are primarily predators. Some hunt by stealth and 
ambush, while others actively pursue their prey. Occasionally snakes 
will scavenge freshly dead animals. Their preys are rodents, lizards, 
birds, and frogs. Snakes also eat bats, frog eggs, snails and slugs while 
some are snake-eaters. Some giant pythons can kill and ea t a deer or 
even a wild pig.  
BREEDING 
The sex organs of snakes are internal. Herpetologist sex snakes by 
using a probe. They can be also sexed by noting the thicker tail base and 
longer tail of the male. Most snakes have specific mating season each 
year (sometimes two seasons) and in a large country with many climatic 
conditions like India, mating seasons may vary from region to region. 
Males follow females by pheromone trail. During this, the males involve 
in ritual fight called combat dance. Most of the time combat dance is 
between males, but sometimes male and female can also involve in 
combat dance. 
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Approximately 25% of the Indian snakes are ovoviviparous, that 
is the eggs develop internally and female bear live young. Livebearers 
include the vine snakes, estuarine snakes, most sea snakes, most vipers 
and pit vipers. All the rest of the snakes are egg layers. Gestation lasts 
between 30-50 days. Snake eggs hatch in 60-70 days; hatching time 
depends on the incubation temperature.  
FANGS8 
All medically important species of snakes have one or more pair 
of fangs in their upper jaw. In India the medically important species are 
Elapidae (cobra and krait) and Viperidae (Russell’s and saw-scaled 
viper).  The fangs are venom-delivering apparatus. The delivery system 
may be primitive or highly developed. In primitive system, the toxic 
saliva is injected into the victim with rear teeth. In highly developed 
system (cobra, krait and viper) venomous glands produce venoms which 
are injected into the victim with the help of highly developed fangs 
either short and fixed or long and sheathed. In Elapidae and Viperidae 
the venomous glands are present at back of the eyes. Elapidae (cobra 
and krait) have relatively short and fixed proteroglyphous front fangs. 
Viperidae (viper, adders, rattlesnakes, moccainsm, lanceheaded vipers 
and pit vipers) have highly evolved long curved, hinged, solenoglyphous 
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front fangs containing a closed venom channel, like hypodermic 
needles. 
MEDICALLY IMPORTANT SNAKES OF INDIA 
India has some of the world’s most venomous snakes and high 
density of human here makes snake bite a common medical problem. 
Accurate statistics are hard to come by, but perhaps half a million 
people are bitten by snakes each year in India. All snakes are protected 
under wild life protection act 1972. The big four snakes of India are 
cobra, krait, Russell’s viper and saw-scaled viper. 
Spectacled cobra 
The biological name is Naja naja.Cobra is derived from the word 
“cobra de capello” (i.e., snake with hood in Portuguese). They are egg 
layers. Male are larger than females. They are nocturnal and diurnal. 
They live in rat holes and termite mounds. They raise the fore body, one 
third to one half of the total body length, to form the characteristic hood. 
They characteristically produce the hissing sound. 
Krait 
The biological name is Bungarus caeruleus.They are nocturnal 
and egg layers. Males are larger than females. They are notorious to visit 
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the dwelling area in search of prey and in that process bites sleeping 
victims. Their bites are usually painless and patient usually presents 
with descending neurological paralysis.  
Saw-scaled Viper 
Their biological name is Echis carinatus. They are nocturnal and 
ovoviviparous. When they are alarmed, they rub the saw scaled edges to 
produce the rasping sound. Females are larger than males. 
Russell’s viper 
The biological name is Duboia russelli. They are viviparous. They 
produce characteristic hissing sound by expelling air through their large 
nostrils. Their bites produce both neurotoxicity and haemotoxicity.  
IDENTIFICATION OF SNAKES 
There is no simple and reliable method to distinguish venomous 
from nonvenomous snakes. The snake’s upper jaw can be examined for 
the presence of fangs but it is too small in Elapidae and is folded back in 
sheath in the case of Viperidae. Snakes can be identified by some 
characteristic features specific to that particular snakes, like the hood of 
cobra, the hissing sound made by the Russell’s viper, the rasping sound 
made by the saw-scaled viper and growl of the king cobra.  
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VENOM COMPOSITION9  
Snakes have more complex of all the venoms. They may contain 
more than 20 components. More than 90% of dry weight is protein and 
the remaining are non protein ingredients.  The protein component is 
mixture of  
¾ Enzymes,  
¾ Non enzymatic polypeptide toxins and  
¾ Non toxic proteins.  
Enzymes like hydrolases, hyaluronidase, L-aminoacid oxidase, 
phosphor mono diesterase, 5 nucleotidase, DNAse, NAD nucleosidase, 
phospholipase A2 and peptidases form the 80%-90% of viperid venom 
and 27%-70% of the elapid venom. Along with these, the elapid venom 
also contains glycerophosphatase, phospholipase B and 
acetylcholinesterase. In addition the Viperid venom contains 
endopeptidase, arginine ester hydrolase, kyninogens, thrombin like 
factor X, prothrombin activating enzyme. Hyaluronidase aids in the 
spread of the venom through the tissue planes. Proteolytic enzymes like 
endopeptidase and hydrolases cause local change in vascular 
permeability leading to edema, blistering and bruising.  
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Non-enzymatic polypeptide toxins are neurotoxins found 
especially in elapid and hydropids, namely postsynaptic alpha 
bungarotoxin and cobrotoxin and presynaptic beta bungarotoxin , 
crotoin and taipoxin. The alpha toxins block the ach receptors and beta 
toxins release the acetylcholine, destroy the presynaptic neuron and 
prevent further release of transmitter. Histamine and serotonin in 
Viperidae cause local pain and permeability. 
Phospholipase A2 is the most widespread and extensively studied 
of all venom enzymes. Under experimental conditions it damages 
mitochondria, red blood cells, leucocytes, platelets, peripheral nerve 
endings, skeletal muscle, vascular endothelium and other membranes, 
and produces presynaptic neurotoxicity activity, opiate like sedative 
effects and the auto pharmacological release of histamine. The nontoxic 
protein is the nerve growth factor.  
Carbohydrates, metals, lipids, free amino acid, nucleosides and 
biogenic amines like serotonin and acetylcholine form the nonprotein 
ingredients of the venom. 
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CLINICAL REATURES OF ENVENOMATION10 
The clinical features of envenomation can be categorized like 
symptoms and signs caused by fear, direct action of various venom 
components on tissues, indirect effect such as complement activation 
and auto pharmacological release of endogenous vasoactive substances, 
effects of treatment and complication due to secondary infections. 
Local swelling 
Most of the poisonous snake bites cause local swelling in the form 
of edema, cellulitis with or without accompanying lymphadenitis. The 
reason for the local swelling is increased vascular permeability caused 
by factors including endopeptidase, metalloproteinase, hemorrhagins, 
membrane damaging polypeptide toxins, Phospholipase and endogenous 
autocoids such as histamine and serotonin. Myotoxins and cytotoxins 
cause local tissue necrosis. Venoms of Viperidae can cause generalized 
increase in vascular permeability leading on to pulmonary edema, serous 
effusion, conjunctival and facial edema and haemoconcentration. 
Significant local swelling is the one in which the edema crosses 
the proximal major joint. This is considered one of the indications for 
administration of ASV. 
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Hypotension and shock 
Some poisonous snake bites presents with hypotension and shock. 
This is part of autopharmocological syndrome caused due to 
vasodilating autocoids. Oligopeptides in Viperidae inhibit bradykinin 
deactivation enzymes and angiotensin converting enzyme leading on to 
hypotension11. Some viper venom can cause direct depression of the 
medullary vasomotor centre19.  Snake handlers are sensitized to life 
threatening anaphylactic reactions. Hypotension is also due to leakage of 
plasma into the bitten limb. Gastrointestinal bleed is also one of the 
reasons for the hypotension shock syndrome. Vasodilatation of 
splanchnic circulation and direct effect on the myocardium also 
contributes. 
Bleeding and clotting disturbance12 
Venom procoagulants cause consumption coagulopathy and leads 
on to bleeding and at extreme cases DIC21, 22. Echis activates the 
prothrombin and Duboia activates factor X and V. Phospholipase is an 
anticoagulant and leads on to bleeding. Thrombocytopenia caused by 
consumption coagulopathy and direct activation of the platelet receptors 
and agglutination also contributes to bleeding disturbances. 
Hemorrhagins directly damage the vascular endothelium and leads on to 
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spontaneous systemic bleeding. Complement activation by alternate 
pathway by elapid and classical pathway by Viperidae will lead o to 
coagulation disturbances. 
Intravascular hemolysis 
  Intravascular hemolysis is caused due to two reasons. First is 
some components (Phospholipase A2 and direct lytic factor) of the 
venom directly act on the RBC membrane and cause hemolysis20. 
Secondly, venom induced disseminated intravascular hemolysis causes 
microangiopathic haemolysis.  
Renal failure13 
Renal failure in snake bite is due to various reasons. The 
morbidity and mortality accompanying snake bite is mainly due to renal 
failure. The injudicious use of ASV may also aggravate the renal failure. 
Most of the time it is acute renal failure improves with dialysis, but 
some time may lead on to persistent acute renal failure or chronic renal 
failure. The following are the reasons. 
¾ hypotension and hypovolemia due to snake bite may lead on to 
prerenal failure leading on to permanent damage if not intervened 
at earlier instance 
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¾ DIC caused by envenomation will cause alteration in blood flow 
to the renal tissues and also there will be accompanying ring DIC 
of the renal vasculature culminating in renal failure. 
¾ Intravascular hemolysis also has pathogenetic significance in 
snake bite induced ARF28,29. 
¾ Direct effect of the venom on the renal tubular cells will lead on 
to toxin induces acute tubular necrosis and renal failure14 
¾ Myoglobinuria and hemoglobinuria accompanying snake 
envenomation will lead on to precipitation of the same in the renal 
tubules leading to renal failure. 
¾ Hyperkalemia due to hemolysis and myolysis leads on to renal 
damage. 
Renal findings in envenomation are20 
¾ Proliferative glomerulonephritis24. 
¾ Toxic mesangiolysis with platelet agglutination, fibrin deposition 
and ischemic changes. 
¾ Distal tubular damage (lower nephron nephrosis) suggesting 
direct venom nephrotoxicity23 . 
¾ Bilateral renal cortical necrosis15. 
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¾ Acute interstitial nephritis25. 
Neurotoxicity 
Neurotoxicity is manifested by ptosis (earliest sign), dysphonia, 
and dysphagia, weakness of the limbs, opthalmoplegia and respiratory 
paralysis. Loss of sense of smell is also proposed as the earliest sign but 
there is no enough documentation of the same. Neurotoxicity is seen in 
envenomation by cobra, krait, mamba and also by Russell’s viper. The 
most common cause of death in neurotoxicity is respiratory paralysis 
followed by bulbar paralysis. Neurotoxicity may be the manifestation of 
either presynaptic or postsynaptic blockade. The postsynaptic 
neurotransmitter dysfunction is managed efficiently and early by 
administration of neostigmine (anticholineesterase drug). Snake bites are 
differentiated on the basis of response to neostigmine. Improvement 
with anticholinesterase drugs are predominantly seen in envenomation 
by Asian cobra, Australasian death adder, Latin American coral snake. 
Ventilator is the mainstay of management for the respiratory paralysis. 
Neurotoxic symptoms can be delayed up to 48 hours, especially in the 
case of krait bite. 
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Rhabdomyolysis16 
Rhabdomyolysis is feature of sea snakes. This is due to the 
presynaptic neurotoxins of sea snakes. Several species of Viperidae (Sri 
Lankan Russell’s viper) also causes rhabdomyolysis. Death in this 
category is due to bulbar or respiratory muscle failure, hyperkalemia and 
renal failure. 
Venom opthalmia17 
Corneal erosions, anterior uveitis, and secondary infections are 
some of the common complications encountered due to direct contact of 
venom in the eye. There are certain varieties of spitting cobra which can 
spit venom up to two meters.  
Elapid envenomation 
Two of the most common neurotoxic snakebite in India belongs 
to Elapidae26. They are krait and cobra. Krait bite usually causes 
minimal local effect. Sometimes the local effects are so minimal that the 
snake bite is not at all suspected as the patient’s presents with 
descending paralysis without any obvious bite marks or local edema. 
Asian cobra bite usually causes tender local swelling, lymphadenopathy, 
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blistering and bullae18. Earliest symptom of neurotoxicity is vomiting27. 
But it is confused with the effect of local indigenous medications. 
Preparalytic symptoms 
The profound paralysis of neurotoxic snake bite is preceded by 
preparalytic symptoms like, contraction of frontalis, blurred vision, and 
paraesthesia around the mouth, hyperacusis, loss of smell and taste, 
headache, dizziness, vertigo. Hyperautonomicity in the form of 
salivation, conjunctival congestion and goose flesh are also 
manifestations of neurotoxicity27. 
Paralysis 
The paralytic symptoms are heralded by ptosis and external 
opthalmoplegia, as the ocular muscles are more sensitive to 
neuromuscular blockade. The time of onset of paralytic symptoms also 
varies with different snakes. Earlier occurrences are seen in cobra bite 
(as early as 15 min) and late manifestation are usually seen in krait bites 
(can be delayed by 10 hours). At later instances palate and pharynx and 
laryngeal paralysis is seen. Pupils are usually dilated. With the onset of 
respiratory paralysis and hypoxia seizures and loss of consciousness can 
occur. Neurotoxicity is relieved by antivenin. Some of the snake bites 
(post synaptic neuromuscular blockade) are neostigmine responsive. The 
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neurotoxic snake bites can be managed with ventilator support only in 
the absence of antivenin or allergy to antivenin. With ventilator support 
only diaphragmatic paralysis improves by 1-4 days, the ocular muscles 
improve in 2-4 days and full motor recovery occurs in 3-7days27. 
Viperidae bite 
The two most common Viperidae which cause major casualty is 
Russells viper and Saw scaled vipr26. Viperidae bite usually causes 
severe local reaction. Swelling of the bitten limb usually occurs in 
fifteen min. persistent bleeding from the fang marks is seen in certain 
cases. In severe cases, extravasations of fluid into the bitten limb may 
occur leading to hypovolaemia and shock27. Necrosis and regional 
lymphadenopathy is seen in majority of the cases. Some cases are 
complicated by compartmental syndrome leading on to prolonged 
morbidity and mortality. Absence of detectable swelling two hours after 
viper bite can be reliably taken as dry bite except tropical rattle, 
Burmese Russell. In these varieties, systemic envenomation can occur in 
the absence of local envenomation. 
Coagulation dysfunction is the main manifestation of the 
Viperidae bite. Persistent bleeding (>10 min), from the fang puncture 
sites, venepuncture sites; old partially healed wounds are first sing of 
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coagulopathy27. Bleeding into the pituitary can lead on to SHEEHANS 
SYNDROME, usually caused by Russell’s in Burma and India27. 
Menorrhagia, antepartum and postpartum haemorrhage, subarachnoid 
haemorrhage, intra cerebral haemorrhage, retroperitoneal haemorrhages 
can complicate the course of the clinical manifestation. Thromboses of 
major arteries such as cerebral, pulmonary and coronary arteries are also 
noted in certain cases. In severe cases microangiopathic hemolysis and 
hemolytic uremic syndrome are documented30. Consumption 
coagulopathy may lead on to disseminated intravascular coagulation. 
Certain cases of viper bites are complicated by hypotensive 
syndrome. Patients presents with hypotension, tachycardia, vasovagal 
syncope and circulatory shock. Anaphylaxis to the venom or the 
antivenom may be the cause of such manifestations. The most common 
cause of death in Russell’s is renal failure. Some cases of Russell’s viper 
presents with combined toxicity (neurotoxicity and haemotoxicity). 
Usually such neurotoxic signs are non responsive to neostigmine and 
take long time for recovery. 
Clinical course and prognosis 
Local swelling is seen in two to four hours in vipers and cytotoxic 
cobra. Maximum swelling is seen in two to three days. Earliest systemic 
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symptom is vomiting. Earliest death is seen in case of elapid 
envenomation. Death can occur as early as one hour due to rapid 
absorption of venom. Some cases of neurotoxicity may need ventilator 
support for as much as ten days. Viperidae deaths are usually due to 
renal failure and it takes many days. 
LABORATORY INVESTIGATIONS 
20 min whole blood clotting test 
Considered the most reliable test of coagulation and can be 
carried out at the bedside without specialist training. It can also be 
carried out in the most basic settings. 
A few ml of fresh venous blood is placed n a new, clean and dry 
glass vessel and left at ambient temperature for 20 minutes. The glass 
vessel should be left undisturbed for 20 minutes and then gently tilted, 
not shaken. If the blood is still liquid then the patient has incoagulable 
blood. The vessel must not have been washed with detergent, as this will 
inhibit the contact element of the clotting mechanism. 
Other useful tests depending on availability 
¾ Haemoglobin/PCV/platelet count/PT/APTT/FDP/D-Dimer 
¾ Peripheral smear 
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¾ Urine tests for proteinuria/RBC/Haemoglobinuria/myoglobinuria 
¾ Biochemistry for serum creatinine/urea/potassium 
¾ Oxygen saturation/PR/BP/postural blood pressure 
¾ ECG/X-Ray/CT/Ultrasound (the use of X-Ray and ultrasound are 
of unproven benefit, apart from identification of bleeding in 
viperine bites. 
MANAGEMENT OF SNAKE BITE IN SOUTH EAST ASIA 
First aid treatment protocol 
Of primary importance is the need to recommend the most 
effective first aid for the victims, to enable them to reach the nearest 
medical facility in the best possible condition. Much of the first aid 
currently carried out is ineffective and dangerous31. 
Recommended method for India32 
¾ R = Reassure the patients. 70% of all snakebites are from 
nonvenomous species. Only 50% of bites by venomous species 
actually envenomate the patient. 
¾ I = Immobilize in the same way as a fractured limb. Use bandages 
or cloth to hold the splints, not to block the blood supply or apply 
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pressure. Do not apply any compression in the form of tight 
ligatures, they don’t work and can be dangerous. 
¾ G.H. =Get to Hospital immediately. Traditional remedies have no 
proven benefit in treating snakebite. 
¾ T = Tell the doctor of any systemic symptoms such as ptosis that 
manifest on the way to hospital. 
This method will get the victim to the hospital quickly, without 
recourse to traditional medical approaches which can dangerously delay 
effective treatment 33.and will supply the doctor with the best possible 
information on arrival. 
Newer methods considered inapplicable in the Indian context. 
Pressure immobilisation méthod (PIM)  
Pressure immobilization has gained some supporters on television 
and in the herpetology literature. Some medical textbooks have referred 
to it. They have not however, reviewed the research, nor considered 
PIM’s applicability in the Indian context. 
PIM was developed in Australia in 1974 by Sutherlan34.He used 
monkeys for the demonstration of the techniques and the results were 
mixed. He argued that a crepe bandage and an integral splint be applied 
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over the wound to a pressure of 55 mm of mercury. The version used in 
India of a bandage alone, Sutherland argued would be ineffective. 
Howarth in 1994 demonstrated that the pressure to be effective 
was different in the lower and upper limbs35. The upper limb pressure 
was 40-70 mm of mercury; the lower limb was 55-70mm of mercury. 
Table for comparison of all the snakes32. 
Features Cobra Krait 
Russells 
Viper 
Saw scaled 
viper 
Local pain/tissue 
damage 
Yes No Yes Yes 
Ptosis / 
neurogogical signs 
Yes Yes Yes! No 
Haemostatic 
Abnormalities 
No No! Yes Yes 
Renal complications No No Yes No 
Reponses to 
Neostigmine 
Yes No? No? No 
Response to ASV Yes Yes Yes Yes 
Anti snake venom 
Anti snake venom is the treatment for snake bite. Anti snake 
venom in India is polyvalent i.e. it is effective against all the four 
common species; Russell viper, common cobra, common krait, and saw 
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scaled viper. There is no currently available monovalent ASV primarily 
because there are no objective means of identifying the snake species, in 
the absence of the dead snake. It would be impossible for the physician 
to determine which type of monovalent ASV to employ in the treating 
the patient. There are known species such as the hump-nosed pit viper 
where polyvalent ASV is known to be ineffective. in addition, there are 
regionally specific species such as sochurek’s saw scaled viper in 
Rajasthan, where the effectiveness of polyvalent ASV may be 
questionable. Further work is being carried out with ASV producers to 
address this issue. 
ASV is produced in both liquid and lyophilized forms. Half life of 
ASV is 26-96 hours36. There is no evidence to suggest which form is 
more effective and many doctors prefer one or the other based purely on 
personal choice. Liquid ASV requires a reliable cold chain and 
refrigeration and has a 2 year shelf life. Lyophilized ASV, in powder 
form, requires only to be kept cool. This is a useful feature in remote 
areas where power supply is inconsistent. 
ASV administration criteria32 
ASV is a scarce, costly commodity and should only be 
administered when there are definite signs of envenomation. Unbound, 
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free flowing venom, can only be neutralized when it is in the 
bloodstream or tissue fluid. In addition, anti-snake venom carries risks 
of anaphylactic reactions and should not therefore be used 
unnecessarily. The doctor should be prepared for such reactions. 
In line with the W.H.O.SEARO, guidelines only if a patient 
develops one or more of the following signs/symptoms will ASV be 
administered32: 
Systemic envenomation 
¾ Evidence of coagulopathy: Primarily detected by 20WBCT or 
visible spontaneous systemic bleeding, gums etc. further 
laboratory tests for thrombocytopenia, Hb abnormalities, PCV, 
peripheral smear etc provide confirmation, but 20WBCT is 
paramount. 
¾ Evidence of neurotoxicity: Ptosis, external opthalmoplegia, 
paralysis etc. 
¾ Cardiovascular abnormalities: hypotension, shock, cardiac 
arrhythmia, abnormal ECG 
¾ Acute renal failure: oliguria/anuria, rising blood creatinine/urea 
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¾ Hemoglobinuria/Myoglobinuria: dark brown urine, urine 
dipsticks, other evidence of intravascular haemolysis or 
generalized rhabdomyolysis (muscle aches and pains, 
hyperkalemia) 
¾ Persistent and severe vomiting or abdominal pain 
Local envenoming 
¾ Local swelling involving more than half of the bitten limb (in the 
absence of a tourniquet) In the case of severe swelling after bites 
on the digits (toes and especially fingers) after a bite from a 
known necrotic species. If the tourniquet have been applied these 
themselves  can cause swelling, once they have been removed for 
1 hour and the swelling continues, then it is unlikely o be as a 
result of the tourniquet and ASV may be applicable. 
¾ Rapid extension of swelling (for example beyond the wrist or 
ankle within a few hours of bites on the hands or feet) 
¾ Development of an enlarged tender lymph node draining the 
bitten limb. 
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ASV administration32 
In the absence of definitive data on the level of en venomation, 
such as provided by ELISA testing, symptomology is not a useful guide 
to the level of envenomation37, 38, 39. Any ASV regimen adopted is only a 
best estimate. What is important is that a single protocol is established 
and adhered to, in order to enable results to be reliably reviewed. 
The recommended dosage level has been based on published 
research that Russell’s viper injects on average 63 mg SD 7 mg of 
venom40. Logic suggests that our initial dose should be calculated to 
neutralize the average dose of venom injected. This ensures that the 
majority of victims should be covered by the initial dose and keeps the 
cost of ASV to acceptable levels. The range of venom injected is 5 mg – 
147 mg. 
This suggests that the total required dose will be between 10 vials 
to 25 vials as each vial neutralizes 6mg of Russell’s viper venom. Not 
all victims will require 10 vials as some may be injected with less than 
63 mg. not all victims will require 25 vials. However, starting with 10 
vials ensures that there is sufficient neutralizing power to neutralize the 
average amount of venom injected and during the next 12 hours to 
neutralize any remaining free flowing venom. 
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There is no evidence that shows that low dose strategies have any 
validity in India41,49,53. These studies have serious methodological flaws: 
the randomization is not proper, the allocation sequence was not 
concealed, the evaluators were not blinded to the outcome; there was no 
a priori sample size estimation, and the studies were underpowered to 
detect the principle outcome.  
The same problem relates to high dosage regimen42, often based 
on Harrison’s textbook of medicine, which was written specifically for 
the U.S. snakes and not intended for use in the developing world. 
No ASV test dose must be administered43,44,45 
Test doses have been shown to have no predictive value in 
detecting anaphylactoid or late serum reactions and should not be 
used27. These reactions are not IgE mediated but complement activated. 
They may also pre-sensitize the patient and thereby create greater risk. 
Recommendation for ASV administration 
Neurotoxic/anti-haemostatic      8-10 vials initial 
Repeat dosage in neurotoxicity  10 vials repeated in 2 hours if  
     worsening of the clinical status  
     and there is no improvement in  
     clinical status. 
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Repeat dosage in haemotoxicity  5-10 vials are repeated if the  
      clotting time  is not normalized in  
      6 hours or if bleeding persists. 
If the clinical condition worsens then it is managed only by 
supportive measures. No additional dosage of ASV should be given. 
All ASV to be administered over 1 hour at constant speed.  
Prevention of ASV reactions-Prophylactic Regimes 
There is no statistical, trial evidence of efficient statistical power 
to show that prophylactic regimes are effective in the prevention of ASV 
Reactions. 
The study by Wan Fan et al showed no benefit and the other two 
showed modest benefit44,45. However, because these studies were 
underpowered to detect the true outcome effect, larger clinical trials are 
needed to conclude that the prophylactic treatment is beneficial. 
Two regimens are normally recommended 
¾ 100 mg of hydrocortisone and 10 mg of H1 antihistamine IV 1-2 
minutes before ASV administration 
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¾ The dose for children is 0.2 mg/kg of antihistamine IV and 
2mg/kg of hydrocortisone IV. 
¾ 0.25-0.3 mg adrenalin 1:1000 given subcutaneously. 
The conclusion in respect of prophylactic regimens to prevent 
anaphylactic reactions is that there is no evidence form good quality 
randomized clinical trials to support their routine use. If they are used 
then the decision must rest on the grounds, such as political policy in the 
case of government hospitals, which may opt for a maximum safety 
policy, irrespective of the lack of definitive trial evidence. 
If the patient has a known sensitivity to ASV then premedication 
with adrenalin, hydrocortisone and anti-histamine is necessary. 
ASV reactions 
Anaphylaxis is life threatening, but despite the reluctance in 
giving ASV due to reactions, if the correct protocol is follow, it can be 
effectively treated and death with46. Anaphylaxis can be rapid onset and 
can deteriorate into a life-threatening emergency very rapidly. 
Adrenaline should always be immediately available. 
The patient would be monitored closely and at the first sign of 
any of the following47; 
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Utricaria, itching, fever, shaking chills, nausea, vomiting, 
diarrhea, abdominal cramps, tachycardia, hypotension, bronchospasm 
and angioedema 
¾ ASV will be discontinued 
¾ 0.5 mg of 1:1000 adrenalin will be given IM 
¾ Children are given 0.01 mg/kg body weight of adrenalin IM 
¾ 100 mg of hydrocortisone and 10 mg of H1 antihistamine, such as 
chlorpheniramine IV.  
If in 10-15 min patient condition has not improved or is 
worsening, a second dose of 0.5 mg of adrenalin 1:1000 IM is given. 
This can be repeated for a third and final occasion. Hypotension and the 
hemodynamic instability should be managed accordingly with 
vasopressors. 
Neostigmine in Snake bite 
Neostigmine is an anticholinesterase that prolongs the life of 
acetylcholine and can therefore reverse respiratory failure and 
neurotoxic symptoms. It is particularly effective for post synaptic 
neurotoxins such as those of cobra and doubtful effectiveness for krait 
and Russells48. 
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MATERIALS  AND  METHODS 
This was a prospective analytical study. The study was conducted 
in a large teaching hospital and research institute catering population of 
forty to fifty lakhs. The period of study was 12 months. All the cases of 
definitive snake bite admitted in the toxicology centre were included as 
the subject of the study. Each case is only recorded as a definite 
snakebite if there is a clear description of a bite from a snake that was 
seen, or if there is clinical evidence of snakebite envenoming.               
A detailed history regarding the type of work, the predisposition 
to snake bite, the preference to treatment (whether indigenous or 
modern), type of indigenous treatment underwent (leaves, powder, bark, 
root, others), the earliest symptom, the reason for coming to modern 
treatment, the accessibility to primary health care centre, the availability 
of the government or private doctor, the difficulty in transportation and 
the advice by the villagers was obtained. The varied clinical 
manifestation at presentation to the hospital was noted with particular 
interest to blood pressure, respiratory rate and effort, the conscious 
level, bleeding manifestations, local reactions and other vitals were 
documented.  
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The basic investigations viz., the routine blood 
investigations(complete blood count , blood urea, serum creatinine, 
blood sugar) was done along with liver function test and urine routine. 
Chest-X-Ray, USG abdomen was done as and when needed. The 20 
minutes whole blood clotting time is done and patients with >20 minutes 
of clotting time was considered as abnormal coagulation.   
Patient with ptosis, dysphonia, dysphagia, breathing difficulty, 
unconsciousness and opthalmoplegia were considered as neurotoxic. 
Bite site edema crossing the major joint is considered as criteria for local 
envenomation. Patient staying in the hospital for more than three days 
are considered for prolonged stay.  These information’s were analyzed 
on the basis of sociocultural, religious and regional beliefs, opinion 
towards indigenous medications, reasons for delayed reporting to 
modern medical care, sequence of symptoms and complications, course 
during the hospital stay, clinical outcome and socioeconomic 
implications. These cases were also were followed up for long term 
effect of snakebite on patients social and economic aspects. Respiratory 
failure, renal failure and prolonged hospital stay were considered as 
signs of serious envenomation and the significance between age, 
occupation, sex, bite to ASV timing and severity of the outcome were 
analyzed. 
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Patients with persistent bleeding tendencies were managed with 
blood products, renal failure patients were given dialysis support and 
respiratory failure is supported with ventilator. Relations between the 
timing of snakebite and the outcome in terms of renal failure, respiratory 
failure and prolonged hospital stay were analyzed. Whenever there were 
severe local reactions of the involved limb surgical management was 
instituted. Vascular surgical investigations and interventions were made 
on requirement basis. Doppler examination of the veins of the limb was 
done and appropriate surgical therapy like fasciotomy was instituted for 
the compartmental syndrome. 
The study was approved by the institute ethics committee and 
informed consent was obtained from each patient. Continuous variables 
were expressed as mean +- standard deviation and discrete variable as 
percentage. The chi square test was used to examine the significance of 
difference. 
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RESULTS 
Hundred of patients of snake bite became eligible for the study 
over a period of 12 months. Out of these 69 (69%) were male and the 
remaining females. The youngest patient was 11 years old. Usually the 
pediatric patients were referred to the Institute of child health situated 4 
km from our hospital. The eldest was 75 yrs of age. In the present study 
72% of the patients belonged to age group 10-40 yrs of age. Only 2% of 
the patient was above 70 yrs of age.  
In the present study, most of the victims were agricultural 
workers. About 76% of the persons ligature as the first aid measure 
during the transport to the medical facility. Forty percent of the patients 
approached indigenous medical practitioner before coming to modern 
treatment. Out of the remaining 60%of the patient 31% approached 
government hospital and 29% of the patient approached private hospital.  
The mean hours from the bite to time of ASV, administration was 
14 hours. Ptosis was the commonest earliest manifestation of the 
victims. First symptom of toxicity was ptosis in 28% of the patients, 
gum bleed in 11% of the study population and double vision in 8% of 
the study population. The mean time of appearance of ptosis was 2 
hours (range 1-21hours), gum bleed was 3 hours (range 1-6 hours), 
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double vision was 1 hour (range 1-4 hours), prolonged clotting was 2 
hours (range 1-9 hours) and vomiting was 1 hour (range 1-3 hours). In 
the present study 34% were bitten by Russell’s viper, 12% by saw 
scaled viper, 19% by cobra, 10% by common krait and 25% by non 
poisonous snakes.  
Most of the bites were outdoor with only 9% occurring indoor. 
There were instances of snake bite during chores of household activities, 
playing, open air defecation and sleeping in the floor.  The study 
population belonged to a perimeter of 50 to 75 km around Chennai. 
However, some patients were referred from for of places like 
Thiruvanamalai, Trichy and Madurai. In all the indoor incidences krait 
was the offending snake. Three percentage of the patient had multiple 
bites.  
Regional lymphadenopathy is present in only 34% of the snake 
bites. Among these cellulitis and lymphadenopathy is seen commonly in 
Viperidae bite and cobra, krait causing insignificant local findings. 
Twenty eight of the study population went for complication. Out of 
which 13% of them were due to renal failure, 9% of the patient was due 
to respiratory failure necessitating ventilatory support. 10% of the study 
population needed supplementation with blood products. Seven 
percentage of the study population succumbed to snake bite, 85% of 
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which was due to ARF. The average period of study was 3-4 days. 
Persons with history of bleeding diathesis, neuromuscular problems, 
renal disease and unknown bite were not included in the study. 
The various variables like sex, occupation, age, type of snake, site 
of bite, type of toxicity, time of first appearance of symptom, time of 
first dose of ASV and complications like ventilator support, dialysis, 
blood products, and death were compared. There was no significant 
relationship between the variables with ventilatory support.  
Acute renal failure and dialysis requirement had definite 
correlation with some of the variables. Eighteen percent of the male 
patients developed renal failure which is significant at 5%. Agricultural 
workers had more predisposition to develop renal failure 
(27%).combined toxicity developed more frequent renal failure (36.8%). 
Time of first dose of ASV and need for hemodialysis had a significant 
correlation. Later the presentation to the health care facility, high 
incidence of renal failure requiring dialysis support. None of the patient 
who received ASV within 6 hours of bite went for renal failure. In 
contrast 26% of the patient who received ASV after 6 hours went in for 
renal failure and is highly significant at 5% level of significance.   
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About 68.4% of the patients of combined toxicity had prolonged 
stay. Forty percentage of patients who received ASV after 6 hours had 
prolonged stay but only 22.9% of the patient who received ASV less 
than 6 hours had prolonged stay. All the patients who received ASV less 
than 6 hours are discharged. Fourteen percent of the patient who 
received ASV 6hours later died. Poisonous snake bite had elevated 
serum alkaline phosphatase. About 62.7% of the patient with poisonous 
snake bite had elevated SAP but only 16% of the non poisonous bite had 
elevated SAP. 
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DISCUSSION 
GENDER 
In the present study, 69 persons were male. This male 
preponderance was similar to findings of other workers. Srimannarayana 
et al found that males are bitten more common49. Hansdac SG et al had 
found that snake bite were 2.5 times more common in males50. Meyer 
WP et al found 85% of the patients to be males, while the study carried 
out by Bhat RN in Jammu way back in 1974,70% of the study 
population wee males51,52. In the study by Paul V et al, male 
preponderance was 75%53. 
The high incidence of snake bite in the male is due to the 
following reasons. India is basically agricultural nation with rich tropical 
climate with lush vegetation. Males are more exposed to snake bite 
because they are the main breadwinners in the Indian family set up and 
women are housewife mainly in the rural setup. So this preponderance is 
mainly an occupational risk. In the case of urban population, the male 
children and adolescents are more commonly affected as they are more 
adventurous and explorative than female counterparts. In the rural setup, 
the female children and adolescents are mainly burdened with taking 
care of the family chores and males are expected to earn. 
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AGE 
In the present study, more than 70% of the victims were within 
the age group 11-40 years. Only 2% of the victims were more than 70 
years old. This was similar to the observation made by Thomas G Glass 
who found 74% incidence in the age of 10-70 years while only 2% were 
more than 70 years54. In the study by Narvencar K 60% of cases 
belonged to 11-40 years of age similar to the present study55. 
The youngest patient was 11 years of age and the oldest was 75 
yrs of gage. The youngest got bitten while going for open air defecation 
and the oldest got bitten while attending work. Due to poor 
socioeconomic condition, the elderly are compelled to work and the 
poor eyesight and the poor general condition makes them an easy target 
for the provoked bites. This was similar to the study by Narvencar K 
where the youngest patient was 12 yrs and the oldest was 70 yrs old55. 
COMMONLY ENCOUNTERED SPECIES 
In the present study 39% were due to Russell’s viper, 19% were 
due to cobra and 12% was due to saw scaled viper, 10% were due to 
krait and 25% were due to non poisonous bites. 
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BITE TO NEEDLE (ASV) TIME 
The average time delay between bite and ASV administration was 
found to be 14 hours. This was similar to many other studies in India. In 
the study by Srimannarayana et al, the average time was 18.3 hours49. 
The delay was due to various reasons and there is significant relation 
between the delay of ASV administration and outcome. 
The delay in ASV administration was due to the following reasons 
¾ Consulting the indigenous medical practioner first and then 
coming for modern medicine consultation. 
¾ Abiding by local customary beliefs and performing pooja’s at 
local temple. 
¾ Lack of transport facilities at some of the remote villages and the 
cost of the transport to the tertiary care centre. 
¾ Fear for the cost of treatment at the modern health care system. 
¾ Availability of the indigenous medicine persons at proximity 
¾ Inadequate experience of the primary health care physician56. 
¾ Hesitation by the Primary Health Officer to institute ASV for the 
fear of anaphylactic reactions 
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TREATMENT PREFERENCE 
Forty percentage of the patient went in for indigenous medicine 
first before attending modern health care facility/ in India, which is 
basically a Hindu country, various age old religious beliefs and customs, 
people tend to think that snake bite is due to previous karma and indulge 
in various offers and pooja’s. India is also the birthplace of Ayurveda, a 
branch of complementary medicine. Though there are proven good 
methods are available for the treatment of various ailment, the country is 
steaming with many quacks who offer inappropriate treatment, most 
commonly leading onto various complications. Thus, the people’s 
preference to indigenous medicine is due to the following reasons 
¾ Easy availability of the indigenous medical practioner in rural 
areas. As most of the people hail from rural area and the 
indigenous medical practioner lives in the community itself the 
people tend to consult him first causing unnecessary delay. 
¾ Victims, as advised by the elderly seek indigenous medical 
practioner. 
¾ As 70%-80% of the bites are nonpoisonous and these poisonous 
bites are claimed to be successfully treated by the indigenous 
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medical practioner, people tend to consult him for poisonous bite 
treatment also. 
¾ Custom and religious beliefs compel them to go for other 
unproven modalities of treatment like performing pooja’s and 
offerings. 
¾ Indigenous medicine is relatively cheaper than modern medicine. 
¾ Most of the people believe that the indigenous medicine would 
halt the progress of envenomation, buying them adequate time to 
reach modern health care. 
¾ False propaganda by the indigenous medical practioner that they 
can cure all kind of envenomation. 
¾ Unavailability of transport facility at remote areas. 
LIGATURE AS FIRST AID 
In the present study 76% of the victims resorted to tying tight 
ligature proximal to the bite site. The victims had a strong belief that the 
ligature prevented any advancement of the venom into the systemic 
circulation. The various scenes in the entertainment media like TV and 
cinema also reinforced this false belief. Some of the victims also related 
their survival to their act of tying the ligature immediately above the site 
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of snake bite. The victim’s behavior is also reinforced by elder’s beliefs 
and opinions. 
COMMONEST SYMPTOM 
In the present study ptosis was the commonest symptom 
encountered (28%). Ptosis was the presenting features in most of the 
elapid envenomation and some of the Viperidae envenomation also 
especially Russell’s viper bites. The median time of appearance of ptosis 
was 2 hours with range of 1-21 hours. Neurological symptoms occurred 
early in cobra bite and Russell’s viper bite. The neurological 
manifestation in krait was delayed, sometimes delayed by 21 hours. This 
might probably due to slow absorption of the venom being deposited in 
the skin deep or subcutaneous tissue by short and sharp fangs. This 
delayed onset of symptoms naturally lead to indifference towards the 
seriousness of the bite and hence delayed reporting to the hospital. 
 Next most common symptom was gum bleed noted in 11% of the 
study group. This in contrast to the Srimannarayana study where 
hemetamesis and hematuria were the commonest presenting complaint, 
(37.7%) and (34.4%) respectively49. 
Vomiting was also one of the commonest symptoms, around 10% 
of the victims presented with it. Most of the episodes of vomiting 
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occurred after consuming indigenous medicines (powder and leaves), 
and it is difficult to conclude whether the vomiting is due to systemic 
envenomation or due to indigenous medication itself. In 8% of the 
study, population double vision was the earliest manifestation.  
The symptoms like gum bleed, ptosis and persistent vomiting, 
compelled the victim to come for modern medicine after consulting the 
indigenous medical practioner. In few cases, hematuria and hemetamesis 
were the earliest manifestation.  
POPULATION AT RISK 
In the present study, the commonly affected group was 
agricultural laborers and manual laborers. The subjects of the study were 
from 50-75 km around Chennai, mainly involved in paddy and 
sugarcane cultivation. This finding confirms that snake bite is 
occupational hazard. In the urban and semi urban population people 
involved in carpentry and those involved in clearing of bushes for 
building construction purposes were mainly affected.  
OUTDOOR VERSUS INDOOR 
In the study 91% of the bites took place in the outdoor activity. 
This proves that snake bite occurs when people interferes in snake’s 
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habitat rather than the vice versa. There were quite a few instances 
where snake bite happened in the indoor activities (9%). In all these 
instances common krait was the offending snake. This is in accordance 
with earlier findings by various authors where people sleeping on the 
floor got bitten by krait. The significance of this is that most of the time 
people couldn’t confirm that it was snake bite and there is always a 
possibility to ignore it as insect bite, as coincidently krait bite doesn’t 
cause any local cellulitis. This is one of the determining factors in the 
late presentation to health care facility. In a recent incident in suburban 
Chennai, three children of the same family succumbed to krait bite while 
they wee sleeping on the floor. This is due to the habit of the snake 
entering the house in search of prey like rats and other rodents. 
SITE OF BITE 
In the present study, 83% of the snake bite site was lower 
extremity. The remaining 17% of the cases involved upper extremity. 
The study also confirmed that most of the cases occurred during 
barefoot walking. Rural Indians are not used to protective wear like 
shoes, especially working in the field. 
 50
SINGLE OR MULTIPLE BITE 
Ninety seven percentage of the bite was single, confirming that 
snake bite occurs as a defensive act by the snakes. Only in three cases, 
there were multiple bites. In all those cases, the snakes are handled and 
no way of escape for the snake, so it repeatedly attacked the victim. 
LOCAL ENVENOMAION 
In the present study 63% of the patient developed edema and 
cellulitis at the bite site. Viper and cobra bite are the most common 
offending species. In the case of krait bite the local envenomation is 
minimal or sometimes absent. This is similar to many studies in the past 
suggesting the absence of local envenomation by the krait bite. 
REGIONAL LYMPHADENOPATHY 
In the present study 34% of the patient developed regional 
lymphadenopathy. Most of the bites were due to viper and cobra. The 
incidence of regional lymphadenopathy in krait bite is very minimal. 
RENAL FAILURE 
In the present study, 11% of the patients had acute renal failure 
requiring dialysis therapy. In India the incidence of ARF following 
snake bite varied from 13 to 32%57,58,59 
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a..  In the study by Paul V et al, the incidence of renal failure is 26% 
and in study by Srimannarayana J 50% of the patients went in for 
renal failure49,53. In Srimannarayana study, only hemotoxic snake 
envenomation was considered for study49. That could have been 
the reason for disparity in the percentage of renal failure. 
The correlation between time of administration of ASV and the 
propensity for renal failure was studied. None of the patient who 
received ASV within 6 hours went for renal failure. But 26% of the 
patient who received ASV 6 hours later went in for renal failure. This 
was found to be significant at 5% level of significance. This confirms 
that early administration of ASV is associated with decreased incidence 
of renal failure. This is similar to outcome in various other studies. In 
the study by Paul V et al 35.7% of the patient who arrived within six 
hours of bite developed ARF, while the incidence of ARF among the 
patient who arrived after 24 hours was 80.6%(P value <0.001)53. 
ASV neutralizes the circulating venom only and no amount of 
ASV will neutralize or combine with venom once the venom is attached 
or adsorbed to target organ i.e. platelets, RBC, vascular endothelium, 
renal tubules, muscle and neuromuscular receptors. So whenever ASV is 
administered lately, the renal damage had already occurred and the ASV 
cannot prevent the renal failure. 
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These findings are similar to the observations made by Vijeth SR 
that the incidence of complications was directly proportional to duration 
of venom in the blood prior to neutralization by ASV and Ash T et al 
that there is positive correlation between severity of renal failure and 
increased interval between bite and ASV administration. 
VENTILATOR SUPPORT 
In the present study about 9% of the patient went in for 
respiratory failure requiring ventilator support. In the study by Paul V et 
al, the incidence of ventilator support was 6%. There was no positive 
correlation between the delayed administration of ASV and higher 
incidence of respiratory failure requiring ventilator support. 
The onset of neurological symptoms, culminating in respiratory 
failure, depends upon the site of bite, amount of venom injected and the 
post bite exertion or exercise by the victim 
DEATH 
The mortality of the present study was 7%. Among that, 85% was 
due to renal failure and the remaining was due to neurological 
complication. In the study by Paul V et al, the mortality was 14% in the 
high ASV dose group and 10% in the low ASV dose group53. In the 
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study by Srimannarayana, the morality rate was 22.2%, 85% of which is 
due to ARF similar to the present study49. None of the patient who 
received ASV within six hours died but 14% of the patients who 
received ASV six hours later died. This was significant at 5% level of 
significance. All these observations reinforce the importance of early 
administration of adequate ASV and prevention of morbidity and 
mortality. 
AVERAGE HOSPITAL STAY 
Average stay period of stay at toxicology ward was 3.71 days. 
This is in contrast to the finding by Paul V et al, where in average period 
of hospital stay was 9.02 in the high dose group and 8.42 in the low dose 
group53. The difference in finding may be due to the fact that the present 
study takes into consideration only the stay at the toxicology ward. Once 
the patients are stabilized, they were shifted to general ward for further 
observation and treatment. 
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CONCLUSION 
This study on snake bite has come out with various conclusions, 
some of them supporting the earlier studies and some of them 
contradicting the previous ones. 
The male preponderance and the highest number of victims in the 
productive age group stamps snake bite as an occupational hazard and 
urges to make implementation of preventive measures. The incidence of 
snake bite can be reduced by the following methods, 
1. Providing protective gear (shoes and gloves) for the agricultural 
workers. 
2. Advising people to carry torch while going to fields during night. 
3. Avoid exploring the dense vegetation and fields during the night 
hours 
4. Advising them to carry a stick or cane and to tap the pathway to 
create vibrations. Snakes actually move out of the pathway 
sensing the vibration 
The delay in the arrival to the hospital and the harmful effects of 
nonscientific methods can be reduced by the following; 
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1. Regulating the media and the press in spreading of unscientific 
methods of treatment. 
2. Sensitizing the people regarding the dangers of adopting 
unscientific methods. 
3. Educating the people regarding the presence of Antisnake venom 
and it’s almost 100% efficiency in preventing death. 
4. Educating people regarding the dangers of ligature. 
5. Training the community health worker in management of snake 
bite victim in the first aid and early hospital referral. 
6. Regulate the indigenous medical practitioners and licensing them 
properly. 
7. Reinforce the primary health care centers and district hospitals to 
treat the snake bite victims and serve as a proper chain of referral. 
8. Training the medical officers in primary health care centre in the 
management of snake bite. 
The delay in the administration of ASV can be prevented by 
properly training the primary health centre doctor in the rational use of 
ASV. Though ASV is administered in the primary health centre 
adequate dose is not given leading to prolonged period of free 
circulating  venom and subsequent complications. Taking all these into 
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consideration the national snake bite task force was formed and national 
treatment protocol for snake bite have been modulated and in the 
process of implementation throughout the country. With this 
multipronged approach the mortality and morbidity associated with 
snake bite can be drastically brought down. 
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 PROFORMA 
Snake Bite Case Sheet (Tick appropriate) 
 
Name :  Age :   
Sex : (if Female date of last menstrual period) 
Antenatal   Y/N  Lactating Y/N 
IP No.   Toxicology No. : 
Address : 
 
Rural / Urban / Semi-Urban  
Informant :   Reliability : Good/ Fair / Poor  
Snake Bite (definite / alleged / unknown) 
Snake Bite details : 
Snake type (if brought by Attenders) 
Location of the Incident : 
 Indoor (home) / Outdoor (work place etc.) 
Site of bite :  Time of Bite : Single Bite / Multiple Bites /  
      Serial Bite : 
 
Patients position at the time of Bite : Sleeping / Working/Bare foot-Y/N 
 
First aid method used : 
Refusal of first aid Y/N : 
Synopsis of Treatment given Outside : 
First aid given by Physician/ Non physician Medical Person / Non Health 
Care person : 
TT given Y/N 
H/O Allergy, Asthma, Atopy, Previous ASV administration : 
Other Medical Illness (details) : 
 
Clinical features  
 
Vital signs : 
Pulse : 
BP (Lying)  (Sitting)  (Standing) 
Respiratory Rate :   Depth (shallow / deep / normal) : 
JVP 
 
General symptoms : 
Nausea, vomiting, postural giddiness, Abdominal Pain, Drowsiness 
 
 
Local symptoms / Signs : 
Pain Y/N,  Warmth  Y/N, Fang Marks Y/N. 
Extent of Swelling (in relation to joints) 
Skin Colour changes Y/N, Bisters Y/N,  Parasthesia  Y/N,  Hypoaesthesia  
Y/N : 
Regional Lymphadenopathy Y/N : 
Distal pulses Y/N, capillary filling time normal / abnormal, Distal sensation 
Y/N : 
 
Coagulopathy 
Epistaxis Y/N, Gum Bleed Y/N, Hematemesis / Malena / Hematochezia  Y/N, 
Hemoptysis  Y/N  
High Colur urine  Y/N,  Vaginal bleed Y/N 
Headache / seizure Y/N 
Skin Petechiae, Purpura, Y/N 
Oral mucoal bleeds / gingival bleed Y/N, conjuctival bleed Y/N 
Bleed from the site of bite / recent wounds Y/N : 
 
Neurotoxic : 
Sense of Smell : Altered : Y/N  (if Yes, give details) 
Sense of Taste : Altered : Y/N (if Yes, give details) 
Drooping of eyelids  Y/N : 
Diploma Y/N, Dysphonia Y/N, Dysphagia  Y/N, Nasal regurgitation Y/N : 
Shortness of breath Y/N : 
Weakness of limbs : (upper limb power  /5, lower limb power   /5) 
Glasgow coma scale : 
Pupils 
Extraocular movement (full / Restricted) 
Facial muscles (unable to hold air in mouth Y/N) 
Gag reflex / palatal movement (normal / abnormal) 
Pooling of secretions oral cavity Y/N : 
Spontaneous breath count : 
Meningeal signs Y/N : 
Fundus : 
 
Cardiovascular : 
Giddiness / Faintness Y/N, frothing at mouth Y/N : 
 
Renal : 
Loin pain/tenderness Y/N, High coloured urine Y/N, Oligoanuria Y/N, 
hiccups Y/N, Pleuritic chest pain Y/N : 
 
Musculotoxic : 
General Myalgia Y/N, Pain, Stiffness Y/N, tenderness of muscles Y/N, 
Trismus Y/N. 
 
CVS/RS/Abdomen Examination 
 
 
Investigations 
Complete blood count (include platelets, peripheral smear study) ; 
 
Urine gross colour and microscopy (on admission)  (After 8 hours) 
 
20 Minute whole blood clotting time (note for serum colour)  
Liver function tests : 
SB/DB : 
ALT/AST/ALP 
CPK (Optional) 
PT, Aptt : 
ABG (Optional; May be risky in coagulopathy) 
ECG 
 
 
SYNDROME CYTOTOXIC / HEMOTOXIC / NEUROTOXIC / 
COMBINATION (SPECIFY) 
 
 
 
 
 
 
 
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
1 22.08 12 50 am Rangasamy 60 M 57015 Tiruvllur Outdoor Arranging things after work Carpenter  Lt Dorsum Foot 5pm Single Y
2 24.08 10 00 am Shankar 34 M 57546 Poompuhar/Villivakkam Outdoor
Saw snake entering 
into arranged things 
Building 
coolie
lt  middile 
finger 1030pm Single Y
3 21.08 90 00 pm Vijayalakshmi 34 F 57525 Sriperampathur Outdoor Taking woods for make fire Coolie   Rt Dorsum Foot 5pm Single Y
4 27.08 03 20 pm Mani 52 M 58386 Hundai Company.Cipcot Outdoor
Taking gunny bag in 
fields Cook lt  thump 09 15 am Single Y
5 22.08 12 noon Kanniyammal 35 F 57210 Chengalpattu Outdoor Cutting wood Coolie  Rt Dorsum Foot 0800am Single Y
6 16.08 08 00 am Velu 55 M 47334 Madurai Outdoor Cutting wood in the forest Coolie  Rt Dorsum Foot 10 00 am Single Y
7 2.07 08 00 am Ramesh 30 M 50186 V.Kotta Andra Outdoor Mango farm Agriculture  Lt Dorsum  Foot 03 30 pm Multiple Y
8 15.06 09 00 am Thimmaiah 35 M 39858 Andra Pradesh Outdoor Sugrcane farm Agriculture  Rt Dorsum Foot 10 50 am Single Y
9 16.03 0445 am Annadurai 34 M 17238 Villupuram Outdoor Ground nut farm Agriculture  Rt Dorsum Foot 0400am Single Y
10 22.03 0430 am Ramalingam 63 M 18871 Cheyyur Outdoor Paddy field Agriculture  Rt Dorsum Foot 0400am Single Y
11 27.02 12 50 am Madavan 48 M 13154 Tiruvannmai Outdoor Ground nut farm Agriculture  Lt Dorsum Foot 1100 am Single Y
12 25.02 0830pm Kannaiyan 55 M 12826 Kerapakkam Outdoor Manuring the field Agriculture  Lt Dorsum Foot 0500pm Single Y
13 7.03 0625pm Subramani 65 M 15279 Arrakonam Outdoor Ground nut farm Agriculture  Lt Dorsum Foot 0345am Single Y
14 23.02 0500pm Ravi 20 M 12579 Tiruvanamalai Ourdoor Sugrcane farm Agriculture  Rt Dorsum Foot 0900am Single Y
15 20.02 0715pm Ramalakshmi 65 F 48802 Tiruvallur Outdoor Sugrcane farm Agriculture Suspected Over Vein 0300pm Single N
16 12.08 0700 pm Usha 19 F 54540 Arakonam Outdoor Farm near home Agriculture  Lt  Leg Dorsal Aspect 0730pm Single Y
17 28.08 630am Mahalingam 36 M 50857 Gumidipoondi Outdoor Around home Agriculture  Lt Leg Third Toe 830pm Single N
18 25.07 1045pm Manikandan 27 M 50187 Arakonam Outdoor Sugarcane farm Agriculture  Rt Foot Dorsum 0300pm Single Y
19 5.07 130am Ramaraj 50 M 44573 Thiruvallur Outdoor Fields working Agriculture  Rt Foot Dorsum 0630pm Single Y
20 16.07 11pm Kanniappan 50 M 47649 Sriperampathur Outdoor Open air toilet Coolie  Rt Foot Dorsum 0800pm Single Y
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
21 19.07 1110pm Vasantha 45 F 48523 Arokonam Outdoor Grass cuting Agriculture  Rt Great Toe 0300pm Single N
22 16.07 0230pm Devi 21 F 47588 Thiruvallur Outdoor In front of the house House wife  Lt Great Toe 0700pm Single Y
23 27.01 1245pm Shenbagavalli 37 F 5875 Thiruvallur Indoor Cooking House wife Lt Dorsum Foot 1100pm Single Y
24 30.03 1000am Murugan 30 M 20670 Tiruvanamalai Outdoor Barefoot walking Coolie  Lt Foot Dorsum 500pm Single Y
25 19.03 0930pm Harikrishnan 20 M 18053 Mothampedu Outdoor Picking stone Unemployed lt index finger 0630pm Single Y
26 19.03 0215am Baskar 34 M 17788 Gumidipoondi Outdoor Urinating in wayside Agriculture Lt Dorsum Foot 0800pm Single Y
27 16.03 0625am Sheeba 19 F 17442 Arakonam Outdoor Cleaning house Sudent lt middle finger 0615am Single Y
28 11.03 1100pm Elumalai 45 M 16103 Thiruvanamalai Outdoor Sugarcane farm Agriculture  Rt Dorsum Foot 10 15 am Single Y
29 4.03 1235 am Elumalai 50 M 14389 Gumidipoondi Outdoor Working in fields Agriculture lt little finger 0400pm Single Y
30 3.04 0230am Asokan 30 M 2142 Thiruvanamalai Outdoor Keeping things in sugrcane field Agriculture  Lt Foot Dorsum 0600pm Single Y
31 9.04 0400am Muthu 13 M 22727 Neelangarai Outdoor Barefoot walking Student  Rt Great Toe 1000pm Single Y
32 7.04 0700am Vennila 41 F 22403 Thiruvallur Outdoor Barefoot walking Coolie  Lt Dorsum Foot 0830pm Single Y
33 31.05 0830pm Praveen 15 M 36010 Arokonam Outdoor Barefoot walking Student  Rt Dorsum Foot 0800pm Single
34 1.06 1255am Gunasundari 19 F 36042 Perambur Chennai Outdoor
Around 
home,barefoot  Coolie  Lt Foot Dorsum 1200am Single Y
35 2.07 0900am Villisamy 47 M 43687 Pondichery Outdoor
Around 
home,barefoot 
walking
Coolie  Rt Foot Dorsum 1200am Single N
36 27.07 1230am Manikandan 25 M 50487 Kanchipuram Outdoor
Returning 
home,barefoot 
walking
Agriculture  Rt Foot Dorsum 0700pm Single Y
37 31.07 0730pm Dhanam 40 F 51186 Sriperampathur Outdoor Around home,cleaning Coolie lt hand 0230pm Single Y
38 4.07 1030pm Selvaraj 25 M 37003 Sriperampathur Outdoor
Returning 
home,barefoot 
walking
Coolie  Lt Great Toe 0730pm Single Y
39 6.06 0830am Chiranjeevi 25 M 37349 Gumdipoondi Indoor Sleeping Agriculture  rt fore arm 1230am Single Y
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
40 3.07 0700am Navaneetham 43 F 44011 Thiruvallur Indoor Sleeping Coolie Rt Great Toe 0400am Single N
41 16.06 0930am Sumathy 25 F 39861 Thiruvallur Outdoor Around home,open air toilet Student Lt Dorsum Foot 1000pm Single Y
42 25.01 0100am Natarajan 36 M 97107 Thiruvallur Outdoor Paddy field/opening water Agriculture
 rt index 
finger 0330pm Single Y
43 23.01 0200am Kotteswaran 30 M 4752 Thiruvallur Ourdoor Barefoot walking Agriculture  Rt Dorsum Foot 0700pm Single Y
44 3.02 1215pm Thenpandian 11 M 7523 Kolathur Outdoor Open air toilet Student Gluteal Region 0600AM Single N
45 12.02 1145am Subramani 23 M 9593 Thiruvallur Outdoor Barefoot walking Agriculture Rt Dorsum Foot 0400pm Single N
46 19.03 0900pm Ramados 55 M 10848 Pooneri Outdoor Ground nut farm Agriculture  Lt Dorsum Foot 0345pm Single Y
47 9.03 1030am Das 42 M 15662 Kodingayur Outdoor Steel plant Machine worker rt thumb 0945am Single N
48 6.03 0430pm Ethiraj 55 M 15025 Arokonam Outdoor Barefoot walking Agriculture  Lt Dorsum Foot 0700pm Single N
49 15.03 1230am Renuka 32 F 16950 Manali Outdoor Barefoot walking Coolie Lt Dorsum Foot 100pm Single N
50 13.04 0100am Shanthi 23 F 23839 Andra Pradesh Outdoor Barefoot walking Student  Rt Foot Dorsum 0730pm Single Y
51 15.04 0800am Munian 35 M 24294 Kanchipuram Outdoor Paddy field Agriculture  Rt Foot Dorsum 0730pm Single N
52 3.06 0430pm Poongavanam 32 F 36594 Tiruvnamalai Outdoor Barefoot walking Agriculture  Rt Foot Dorsum 0710pm Single N
53 5.07 0630pm Bhavani 17 F 44836 Tiruvanamalai Indoor Arranging things after Student Rt Leg 0700pm Single Y
54 6.08 11.30am Mhadavan 29 M 52999 Thiruvalur Outdoor Brinjal field Agriculture Rt Thigh 0600am Single N
55 5.08 1040pm Bhavani 12 F 52838 Chennai Outdoor Barefoot walking Student  Lt Foot Dorsum 0730pm Single N
56 27.07 900pm Stephen 21 M 50759 Sholinganalor Outdoor Bathing Student  Rt Foot Dorsum 0730pm Single N
57 18.06 1230am Reshmi 30 F 40139 Perungudi Outdoor Barefoot walking House wife  Lt Foot Dorsum 1100pm Single N
58 15.06 1030pm Dhanasekar 30 M 39829 Avadi Outdoor Barefoot walking Government emplo  Lt Foot Dorsum 0800pm Single N
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
59 2.07 0930pm Karthik 28 M 43973 Porur Indoor Arranging tings Coolie  Lt Great Toe 0530pm Single Y
60 16.07 0500pm Anu 22 M 47608 Avadi Indoor Sleeping House wife lt hand elbow 0330pm Single N
61 24.07 0320am Latha 25 F 49634 Madarambakam Indoor Sleeping House wife  Rt Foot Dorsum 1230am Single Y
62 31.01 0815am Ravi 30 M 6665 Ponneri Outdoor Barefoot walking Government emplo  Lt Foot Dorsum 0900pm Single N
63 1.02 0500pm Dhayalan 40 M 7127 Kanchipuram Outdoor Barefoot walking Coolie  Lt Foot Dorsum 0600pm Single Y
64 12.04 0115am Mary Margret 32 F 23571 Chennai Outdoor Sitting in front of house House wife
Rt Gluteal 
Region 0700pm Multiple N
65 5.06 1230am Govindammal 30 F 37024 Sriperampathur Outdoor Barefoot walking Coolie Rt Calf 0800pm Multiple N
66 4.08 1255pm Munikrishnan 31 M 36576 Gumpidipoondi Outdoor Arranging things Coolie  rt hand finger 0800am Single N
67 1.09 0900pm Munusamy 60 M 59620 Arokonam Outdoor Bitter melon field Agriculture lt middle finger 1130am Single Y
68 30.08 0945pm Kumar 22 M 59177 Kolathur Outdoor Barefoot walking Student  Lt Middle Toe 0630pm Single Y
69 28.08 1230pm Elizabeth Rani 32 F 58581 Sriperampathur Outdoor Sitting in temple Export worker  lt middle finger 0900pm Single Y
70 7.05 0900pm Venkatesan 28 M 29828 Near Chetinad Hospital Outdoor Barefoot walking Coolie  Rt Big Toe 0800pm Single Y
71 27.05 0900pm Balamurugan 25 M 34872 Thiruvallur Outdoor Open air toilet Coolie  Lt Foot Dorsum 0600pm Single N
72 7.05 1150pm Atchaya 24 M 29850 Gumpidipoondi Outdoor Open air toilet Coolie  Lt Calf Reion 0630pm Single Y
73 6.05 1030pm Ameresan 17 M 29526 Kanchipuram Outdoor Climbing tree Agriculture  lt middle finger 0330pm Single Y
74 30.04 0300pm Stanley Andrews 48 M 28101 Ambattur Outdoor Handling snake
Profe.snake.c
atch rt arm 0115pm Single Y
75 28.05 1030pm Meenakshi 25 F 35221 Tiruvanamalai Outdoor Barefoot walking House wife  Rt Dorsum Foot 0430pm Single Y
76 19.04 545am Babu 35 M 25303 Gumpidipoondi Outdoor Working in fields Agriculture  Lt Dorsum Foot 0700pm Single Y
77 28.05 0600am Manikandan 13 M 34911 Sriperampathur Indoor Sleeping Student Lt Dorsum Foot 0300am Single Y
78 27.04 0200pm Rajendran 39 M 27471 Kanchipuram Outdoor Outside house Agriculture  Rt Dorsum Foot 0730pm Single Y
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
79 15.03 0800pm Renuka 32 F 16950 Chennai Outdoor Barefoot walking Coolie Lt Dorsum Foot 0600pm Single Y
80 15.03 0800pm Janaki 55 F 17211 Chennai Outdoor Barefoot walking Coolie Rt Dorsum Foot 0600pm Single Y
81 22.03 0900pam Sathishkumar 27 M 18654 Kanchipuram Outdoor Paddy field Agriculture Lt Dorsum Foot 0700pm Single Y
82 1.03 0700am Vibhu 22 M 13894 Chennai Outdoor Barefoot walking Student Lt Dorsum Foot 0600am Single N
83 3.03 0900pm Mohan 41 M 14193 Sriperampathur Indoor Sleeping Agriculture lt hand 0600pm Single Y
84 16.01 0445pm Kullamma 75 F 3214 Villupuram Outdoor Working in fields Agriculture Lt Dorsum Foot 0600am Single Y
85 28.01 1140pm Ayyamarappan 40 M 6064 Avadi Outdoor Barefoot walking Government emplo Rt Dorsum Foot 0700pm Single Y
86 23.02 0910pm Vishvanathan 25 M 5012 Chennai Outdoor Barefoot walking Student Lt Dorsum Foot 0600pm Single N
87 13.02 1145am Eshwaran 32 M 10071 Chennai Outdoor Barefoot walking Government emplo Lt Dorsum Foot 0945am Single N
88 15.02 0640pm Gowi 18 F 10638 Ponneri Outdoor Sugarcane farm Agriculture Rt Dorsum Foot 0645am Single Y
89 17.02 1115am Murugama 50 F 11001 Thiruvallur Outdoor Barefoot walking Coolie Lt Dorsum Foot 0715am Single N
90 23.02 0800pm Asish 23 M 12563 Thiruvallur Outdoor Barefoot walking Student Rt Dorsum Foot 0800am Single N
91 27.02 0930pm Pradeep 37 M 13365 Chennai Outdoor Around home Government emplo Lt Dorsum Foot 0630pm Single N
92 26.03 1000am Shanmugam 40 M 19842 Thirutanni Outdoor Barefoot walking Coolie Rt Dorsum Foot 0600am Single N
93 18.03 0900pm Bagiyalakshmi 68 F 25273 Thiruvanamalai Outdoor Working in fields Agriculture lt hand 0900am Single Y
94 22.04 0900pm Thyagu 16 M 26145 Thiruvallur Outdoor Barefoot walking Student Lt Dorsum Foot 0600pm Single N
95 27.04 0800am Rajendran 38 M 27471 Kanchipuram Outdoor Paddy field Agriculture Lt Dorsum Foot 0800am Single Y
96 9.05 1100am Yabish 19 M 30395 Thiruvallur Outdoor Barefoot walking Student Rt Dorsum Foot 0900am Single N
97 17.05 0900pm Sivakumar 25 M 32226 Chennai Outdoor Barefoot walking Government emplo Rt Dorsum Foot 0600pm Single N
98 21.05 0900pm Rajeshwari 39 F 33080 Chennai Outdoor Barefoot walking House wife Rt Dorsum Foot 0700pm Single N
99 3.06 1000am Poongan 38 M 36594 Thiruvanamalai Outdoor Sugarcane farm Agriculture Lt Dorsum Foot 0800am Single Y
Sr 
No
Dt of 
Admission Time Name Age Sex IP No  Place In/Outdoor Work
      
Occupation
 Site of 
Bite UL Site of Bite LL Time
  No of 
Bite Iigature
100 9.06 0600pm Munusamy 75 M 38201 Thiruvallur Outdoor Paddy field Agriculture Rt Dorsum Foot 0600pm Single Y
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
P G Vomiting 1h Russel 1h 8h Kept Under Observation C Y
P PR Ptosis 6h Krait 6h 2h30m N N 6h Breathing difficulty
G Non poisonous 4h
P G Non poisonous 6h
P G Nonpoisonous 4h N-localised swelling
P G Vomiting 3h Russels 4h 144h Treated At Madurai H Y Y
NP NA Vomiting 1h Russels 98h 98h Treated Native Medicine H Y
Leaves NP NA Gum Bleed 4h Russels 12 h 98h Treated In Andra C Y 4h
P G Blurring Of Vision 1h Russels 2h 48h Treated In Tiruvanamalai H Y Y
P PR Blurring Of Vision 1h Russels 2h 36h Treated In Chengalpattugh H Y
Powder NP NA Blurring Of Vision 1h Russels 2h 36h Treated In Vandavasi C Y Y 3h
Powder NP NA Hematuria 17h Russels 27h 27h Observed In Home Non poisonous N
P G Prolonged Clotting 1 h Russels 1h 14h Treated In Arokonam Gh H Y
Leaves NP NA Prolonged Clotting 1hr Russels 1h 56h Treated In Tiruvanamalai C Y Y 24h
Leave Uice NP NA Bleeding Gums 30min Russels 1h 4h30m Treated  In Tiruvallur Gh H N
Leaves NP NA Dizziness 25min Saw scaled 1h 25 min 12h Shutteled Through Various Hospitals H Y
Leaves NP NA Bleeding Gums 6h Saw scaled 10hr 10hr Kept In Ponerigh H Y Y
Leaves NP NA Blurring Of Vision 1h Russels 1h30min 7h30min Thiruvallur Gh C Y Y 1h30min
P G Ptosis 2h Russels 2h 7h30min Tiruvallur Gh C Y 2h
Powder NP NA Gum Bleed 1h Russels 3h 3h Travelling C Y Y 1h30min
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
P PR Ptosis 21h Russels 24h 24h Went Home After Getting First Aid C N Y 21h
P G Clooting Time Incre 9h Sawscaled 9h 19h Under Observation At Arakonam Gh H N Y
Leaves NP NA Headache 4h Sawscaled 12h 12h Travelling H Y Y
NP NA Bleeding Gums 2h Russels 10h 5days Treated In Tiruvanamalai C Y Y y
P PR Bleb 2h Russels 8h 3h Travelling H Y Y
P G Ptosis 2h Russels 4h 4h Travelling C Y Y 2h
Leaves NP NA Persistent Pain immediate Russels 4h 12h Treated In Kancheepuram Gh H Y Y
Leaves NP NA Vomiting 1h Russels 2h 12h Travelling C Y Y y
P G Blurring Of Vision 4h Sawscaled 4h 12h Treated In Ponneri Gh H N Y
P G Hemetemesis 2h Russels 2h 9h Treated In Tiruvanamalai H N Y
P PR Bleeding Gums 4h Sawscaled 6h 6h Was In Home H Y Y
Leaves/Po
wder NP NA Double Vision 3h Cobra 11h 11h
Bus Facility Not 
Available N Y Y
P G Prolonged Clotting 2h30m Sawscaled 2h30m 24h Treated In Arokonam Gh H N Y
P G Prolonged Clotting 1h Sawscaled 1h 1h Direct H Y Y
P G Ptosis 12h Krait 12h 33h Treated In Jipmer N N N 24h
P G Ptosis 1h Russels 1h 5h Travelling C Y Y 1h30min
P G Ptosis 30min Cobra 1h 5h Travelling N N Y 30m
Leaves NP G Dysphonia 30min Cobra 3h 3h Travelling H N Y 1h Y
Leaves NP NA Ptosis 1h Krait 8h 8h Tavelling H N N 1h
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
P G Ptosis 1h Krait 1h 3h Travelling N N N 1h
Powder NP NA Double Vision 1h30m Cobra 1h30min 10hr Treated At Ponneri N Y Y
Powder/Lea
ves NP NA Ptosis 6h Cobra 8h 8h Native Treatement N N Y 6h
Leaves NP NA Ptosis 3h30m Russels 7h 7h Native Treatement C Y Y 3h30m
P PR Ptosis 30min Cobra 2h 6h Treated At Private N N Y 30m
Leaves NP NA Ptosis 9h Cobra 20h 20h Native Treatement N Y Y 9h
Liquid NP NA Blurring Of Vision 1h Krait 2h 5h Treated At Ponneri N N Y
P G Double Vision 1h30m Cobra 1h30min 45m Direct N N Y 2h
Leaves NP NA Ptosis 1h Cobra 15h 21h N N Y 1h
Leaves NP NA Ptosis 1h Cobra 2h30m 2h30m N Y Y 1h
Leaves NP NA Ptosis 45m Cobra 1h 5h N Y Y 45m
Snake 
Stone NP NA Ptosis 12h Russels 18h 36h C N Y 12h
P G Prolonged Clotting 2h Russels 2h 43h H Y Y
P G Local Envenomation 1h Saw scaled 5h 24h Local N Y
P PR Prolonged Clotting 2h Saw scaled 6h 6h H Y Y
P G No Symptoms Nonpoisonous 3h Non poisonous N N
P G No Symptoms Nonpoisonous 2h Non poisonous N N
P G No Symptoms Nonpoisonous 1h30m Non poisonous N N
P G No Symptoms Nonpoisonous 3h Non poisonous N N
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
P PR No Symptoms Nonpoisonous 5h Non poisonous N N
P PR No Symptoms Nonpoisonous 2h Non poisonous N N
Leaves NP NA Ptosis 2h Krait 2h 2h N N N 2h
P PR No Symptoms Nonpoisonous 12h Non poisonous N N
P PR Prolonged Clotting 2h Sawscaled 2h 47h H N Y
NP NA No Symptoms Nonpoisonous 6h Non poisonous N N
P G No Symptoms Nonpoisonous 3h30m Non poisonous N N
P PR No Symptoms Nonpoisonous 5h Non poisonous N N
Powder NP NA Prolonged Clotting 1h30m Russels 1h30min 9h Treated At Arokoam H N Y
P PR Prolonged Clotting 5h Russels 5h 3h Travelling H N N
P PR Ptosis 4h Krait 15h 15h Observed At Private Hospital N N N 4h
Leaves NP NA Hemetemesis 8h Sawscaled 25h 25h Went Home After Getting First Aid H N Y
P PR No Symptoms Nonpoisonous 3h Travelling Non poisonous N N
P G Dysphonia 2h Cobra 5h 5h Travelling N Y N
Leaves/Po
wder NP NA Dysphonia 30min Cobra 2h 7h Travelling N Y Y 8h
P G Ptosis 7h Cobra no asv 2h Travelling Dry bite N Y 7h
P PR Giddiness 6h Nonpoisonous no asv 6h Travelling Non poisonous N N
P G Ptosis 1h Russels 10h 10hr Treated In Private C N Y 1h
P G Dysphonia 2h Cobra 3h 3h Travelling N Y Y 3h
Leaves NP NA Local Envenomation 1h Cobra 1h 5h Travelling Local N Y
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
P PR Ptosis 1h Cobra 2h 2h Travelling N Y Y 1h
P PR No Symptoms Nonpoisonous 2h Travelling Non poisonous N N
Leaves NP NA Bleeding Gums 3h Russels 6h 72h Treated  At Chengalpattu C Y Y 5h
P PR No Symptoms Nonpoisonous 1h Travelling Non poisonous N N
Leaves NP NA Ptosis 3h Krait 3h 27h Treated In Kancheepuram Gh N N N 3h
Leaves NP NA Ptosis 4h Russels 4h 10hr Treated In Villupuram C Y Y 4h
P NA Ptosis 2h Cobra 4h 4h Travelling N N Y 2h
P PR No Symptoms Nonpoisonous 3h Travelling Non poisonous N N
P PR No Symptoms Nonpoisonous j2h Travelling Non poisonous N N
Leaves NP NA Ptosis 1h Cobra 3h 12h Treated In Ponneri Gh N N Y 1h
Leaves NP NA No Symptoms Nonpoisonous 4h Travelling Non poisonous N N
P PR Ptosis 2h Krait 3h 12h Treated In Thiruvallur N N N 2h
P PR No Symptoms Nonpoisonous 3h Travelling Non poisonous N N
P PR No Symptoms Nonpoisonous 4h Travelling Non poisonous N N
Leaves NP NA Bleeding Gums 3h Russels 5h 36h Treated In Tiruvanamalai C Y Y 6h
P PR No Symptoms Nonpoisonous 3h Travelling Non poisonous N N
Powder NP NA Bleeding Gums 4h Russels 6h 30h Treated In Kancheepuram Gh H Y Y
P PR Ptosis 2h Krait 5h 5h Travelling N N N 2h
P PR No Symptoms Nonpoisonous 3h Travelling Non poisonous N N
P PR No Symptoms Nonpoisonous 2h Travelling Non poisonous N N
Leaves NP NA Bleeding Gums 2h Russels 4h 26h Treated In Tiruvanamalai H Y Y
 First Aid 
Method
Firstaid 
physcia
n/nonph
yscian
Private(pr)/
governmen
t(g)/native(
na)
First symptom Time of Apearance Type of Snake
Time of First 
dose of ASV
Bite to GGH 
Admission Reason for delay
Neurotoxicity / 
hemotoxicity/ 
Conmbined
Regional 
Hymphade
nopathy
Llocal 
Envenomati
on
         
Ptosis
Respiratory 
paralysis
Powder NP NA Bleeding Gums 1h Russels 12h 48h Went Home After Getting First Aid C Y Y 4h
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
Dysphonia/dysphagia 18 1 3 11 94 N N N 18 Discharged 5 Persistent edema
no 28 0.9 3.4 11.5 76 N N N 18 Discharged 5 Intense myalgia,LDH 735
Giddiness only 34 0.7 4 10 78 N N N NO ASV Discharged 2 Giddiness
No symptoms 21 0.7 3.1 13 97 N N N NO ASV Discharged 2 Dry bite by poisonous snake
No symptoms 18 0.9 3.8 12.2 345 N N N NO ASV Discharged 3
Presented with arf-olig 165 12 3.3 10 126 N Peritoneal N 18 Yes Discharged 14
Presented with arf-olig 187 15 5 9 176 N Peritoneal N 18 Yes Death 12 Late presentation
4h 12h Presented with arf-olig 223 18.7 3.9 11.5 75 Hemodialysis N 18 Yes Discharged 13 Late presentation
Presented with arf-olig 150 2.8 4.5 10 159 N Hemodialysis Ffp/platelets 18 Yes Discharged 14 Ref original
12h Presented with arf-olig 79 2.8 4.4 12 155 N Hemodialysis N 18 Yes Discharged 11
Presented with arf-olig 90 5.3 4.8 4.4 83 Y Hemodialysis Ffp/platelets 18 Yes Death 16 Arf/dic/schock
122 5.7 5.4 10 65 N Hemodialysis N NO ASV Yes Discharged 13 Myocar. Infarct inf wall with arf.no asv
32 1 4 13 76 N N N 8 Discharged 3 Low dose
Presented with arf-olig 143 5 4.6 12.3 148 N Hemodialysis N 18 Yes Discharged 11
32 1 4.2 11 98 N N N 18 Discharged 2
Unconsious 
immediately -pain 
h kOnly clotting time 
prolonged 32 1.2 3.2 10 89 N N Ffp 18 Discharged 4 Pregnant 9mon
6h 34 2.2 3.4 12 100 N N N 18 N Discharged 3
22 1.5 3.6 9.5 154 N N N 18 N Discharged 2
no Clotting time pro.1h30m 31 1 2.1 13 140 N N N 18 N Discharged 1
6h no All manifestation 37 1.1 3.1 13 234 N N Ffp/platelets 18 N Discharged 4 Total billurubin
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
Altered taste 19 0.8 3.6 9.6 140 N N N 18 N Discharged 1
30 0.8 3.4 12.5 140 N N N 18 N Discharged 1
Clotting time prolonged 20 0.9 3.7 12 154 N N 5 N Discharged 2
y no Presented with arf-olig 176 5.5 5.3 10 243 N Hemo+perito Ffp/platelets 18 Yes Ama 10
Dic/renal failure/toxic 
optic neuritis
Bleb in 2hr 24 1.2 3.6 14.4 160 N N N 13 N Discharged 2 Discolouration
no Eom restricted 29 0.9 2.9 15.5 154 N N N 13 N Discharged 1
22 1 3.6 12.3 111 N N N 18 N Discharged 2
y no Heamaturia only 34 1.1 3.8 12 165 N N N 18 N Discharged 2
Blurring +ct prolonged 40 1.2 3.8 11.8 156 N N N 18 N Discharged 1
Gumbleed,hematuria,o
thrs 144 4 4.5 10 176 N N
Ffp/platele
ts 18 Yes Death 1
Loss of vision(optic 
neuritis,viterous 
hemorrhage),sluggish 
Lymphadenitis first 1h 33 1 3.6 10.8 21 N N Ffp 18 N Discharged 2
Lymphadinitis 
first,profuse gum 
Tansient double vision 18 0.7 4.3 9.3 116 N N N 8 N Discharged 3
No symptoms 39 1.2 3.8 13 379 N N N 6 N Discharged 1
Exremely pain 
lymphade 28 0.7 3.2 14 85 N N N 13 N Discharged 3
Extremely painful 
lymphadenopathy
Cent.pon. Myelinolysis 100 1.9 3.2 11 211 Y(3days) N Ffp/platelets 18 N Death 22
Alcoholic,prolonged 
ventilation,hepatitis 
like picture(AST/ALT-
no Prolonged clotting 22 0.8 3.1 14 215 Y(24h) N N 18 N Discharged 6 Ldh-1465
yes Dysphonia/dysphagia 34 1 2.7 11.8 187 N N N 18 N Discharged 3
yes Prolonged bite 25 0.8 3.5 12.5 92 Y(36h) N N 18 N Discharged 2
Dysphonia/opthalmople
gia 34 1 3.9 13 98 Y(12h) N N 18 N Discharged 2
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
Giddiness and 
headache 35 1 4 10 95 N N N 12 N Discharged 1
Excruciating pain 23 1.1 3.7 12 87 N N N 18 N Discharged 2
Persistant vomiting 32 0.9 4.1 14.7 256 N N N 18 N Discharged 2
Prolonged clotting time 134 1.2 3.9 12.8 176 N N Ffp/platelets 18 N Discharged 7
Transient rise of 
RFT,subsided without 
dialysis
yes Gluteal welling 32 1 3.5 11 306 N N N 18 N Discharged 2
yes 33 0.8 4.1 12.4 179 N N N 18 N Discharged 5
no No asv at ggh 28 1.4 3.6 11.3 184 N N N 14 N Discharged 2 No asv at ggh
yes Direct admission 25 0.7 3.6 15.7 156 Y(24h) N N 13 N Discharged 4 Improved over 24 h
yes 70 2.4 3.9 14 175 Y(24h) N N 18 N Discharged 11
Transient rise of 
RFT,subsided without 
dialysis
yes 22 0.7 0.4 9.8 101 Y(4h) N N 18 N Discharged 5 Cpk 706,cpkmb 58,ldh 583
yes Breathing dificulty 22 1 3.8 11.4 176 N N N 18 N Discharged 5 Blurring of vision for 6 days
no 98 2 4.2 10.7 198 N N N 18 Yes Discharged 3 Diplopia and numbness persisting
Lotting only prolonged 26 1.2 3.3 13.7 200 N N N 18 N Discharged 2
Immediate 
unconsiousness(pain 
shock),clotting only 
prolonged
24 1 3.6 8.5 152 N N N 10 N Discharged 2 Only local envenomation
Clotting prolonged 31 1 3.4 12 146 N N N 8 N Discharged 1 Transient blurring of vision
22 0.9 3.8 11 78 N N N NO ASV N Discharged 1
25 0.9 4 11.6 87 N N N NO ASV N Discharged 1
No symptoms 21 0.7 3.4 10.6 31 N N N NO ASV N Discharged 2
No symptoms 22 0.7 4 13 74 N N N NO ASV N Discharged 1
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
No symptoms 17 0.8 3 15 76 N N N NO ASV N Discharged 1
Headache 26 0.8 3.1 12 105 N N N NO ASV N Discharged 1
no Headache 23 0.7 3.6 10.6 196 N N N 8 N Discharged 1
No symptoms 17 0.7 4 13.8 144 N N N NO ASV N Discharged 2
Hemo+edema 32 1 3.7 13 97 N N N 10 N Discharged 2
Local edema 17 0.7 3 15 63 N N N NO ASV N Discharged 1
Local edema 20 0.9 3.2 11.5 178 N N N NO ASV N Discharged 1
Local edema 19 1 3.8 10.9 112 N N N NO ASV N Discharged 2
29 0.7 3.6 13.9 85 N N N 10 N Discharged 2
No local 
edema,lynadeno 19 0.8 3.9 10.6 194 N N N 8 N Discharged 2
No local 
edema,lynadeno 18 0.6 3.3 10.6 98 N N N 18 N Discharged 3
Epistasis, 32 0.7 3.7 12 154 N N N 14 N Discharged 2
17 0.7 3.2 8 236 N N N NO ASV N Discharged 2
No ptosis 21 0.8 3.8 12.3 118 Y(24h) N N 18 N Discharged 4
Late ptosis 17 0.8 3.5 11.1 187 N N N 13 N Discharged 2
Transient ptosis 19 0.9 4.3 13 112 N N N NO ASV N Discharged 2 Transient ptosis,no asv
26 1 3.6 10 93 N N N NO ASV N Discharged 1
Arf 87 3.3 5.4 10 187 N Hemo 18 Yes Discharged 9
Compartmental 
syndrome 21 0.9 3.2 11 431 N N N 18 N Discharged 2
Compartmental 
syndrome
50 1.4 4.1 13.5 82 N N N 14 N Discharged 2
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
Compartmental 
syndrome 32 1.1 3.7 12.1 108 N N N 18 N Discharged 3
Local edema 22 0.7 3.8 11.1 67 N N N NO ASV N Discharged 1
3h Presented with arf-olig 98 4.5 5 10 199 N Hemo N 18 Yes Discharged 18
Local edema 20 0.8 3.8 13 76 N N N NO ASV N Discharged 2
No local 
edema,lynadeno 33 1.1 4.1 12 136 N N N 18 N Discharged 1
Clotting prolonged 43 1.2 3.6 11 218 N N N 18 N Discharged 4
21 1.1 4.1 10.7 165 N N N 13 N Discharged 2
Local edema 20 1 3.5 10.9 87 N N N NO ASV N Discharged 2
Local edema 20 1.3 3.6 12 76 N N N NO ASV N Discharged 1
yes 34 1.1 4.1 10 66 N N N 13 N Discharged 1
Local edema 31 1 3.9 11 84 N N N NO ASV Discharged 1
No local 
edema,lynadeno 28 1.1 4.2 13 191 N N N 18 N Discharged 4
Local edema 22 1 4.1 14 65 N N N NO ASV N Discharged 1
Local edema 30 1.1 3.9 12 56 N N N NO ASV N Discharged 1
41 1 4.1 10 231 N N N 18 N Discharged 1
Local edema 23 0.8 3.9 14 46 N N N NO ASV N Discharged 1
41 1.4 4 11 201 N N N 18 N Discharged 2
No local 
edema,lynadeno 22 1 3.8 12 76 N N N NO ASV N Discharged 3
Local edema 31 1.2 4.1 14 48 N N N NO ASV N Discharged 1
Local edema 30 1 3.9 12 65 N N N NO ASV N Discharged 1
43 1.3 4 14 169 N N N 18 N Discharged 2
 
Bleeding 
gums
Hematur
ia
Hemete
mesis
Neosti
gmine 
res.
Other syptoms
B.ure
a(mg
m/dl)
Sr.Cre
atinine 
(mgm/
dl)
Potassi
um 
(meq/dl)
Hemogl
obin SAP
Ventilatory 
support Dialysis
Blood 
products
No of 
ASV 
used
ARF Outcome Period of stay
Point of 
interest/specific 
symtom
Presented with arf-olig 104 4 5.4 10 261 N Hemo Ffp/platelets 18 Yes Death 8
